Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosis by Zou, Wei & Teitelbaum, Steven L.




Absence of Dap12 and the αvβ3 integrin causes
severe osteopetrosis
Wei Zou
Washington University School of Medicine in St. Louis
Steven L. Teitelbaum
Washington University School of Medicine in St. Louis
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation




The Rockefeller University Press  $30.00
J. Cell Biol. Vol. 208 No. 1 125–136
www.jcb.org/cgi/doi/10.1083/jcb.201410123 JCB 125
Correspondence to Steven L. Teitelbaum: teitelbs@wustl.edu
Abbreviations used in this paper: Ab, antibody; BMM, BM macrophage; ITAM, 
immunoreceptor tyrosine–based activation motif; M-CSF, macrophage colony-
stimulating factor; RANKL, receptor activator of nuclear factor B ligand.
Introduction
The osteoclast is the principal skeletal resorptive cell with the 
capacity to degrade the organic and inorganic matrices of bone 
(Novack and Teitelbaum, 2008). It exerts its bone-degrading 
properties by attaching to mineralized matrix and forming actin 
rings that isolate the resorptive microenvironment from the gen-
eral extracellular space. Skeletal degradation, by the osteoclast, 
is initiated by transport of H+ and Cl ions into the resorptive 
space juxtaposed to bone. The consequential acidification mo-
bilizes the mineral phase of bone, thereby exposing its organic 
matrix, which is degraded by exocytically transported cathepsin 
K. Resorption, therefore, requires delivery of bone-degrading 
molecules to the bone/cell interface involving polarization of 
the osteoclast via organization of its actin cytoskeleton.
Immunoreceptor tyrosine–based activation motif (ITAM)–
containing co-activators, which participate in innate immunity, 
are also central to osteoclastic bone resorption (Humphrey et al., 
2005). Because their extracellular domains are small and there-
fore incapable of recognizing ligand, ITAM proteins associate 
via their transmembrane regions, with plasmalemma-residing 
immunoreceptors. In consequence, a host of signaling cascades 
regulating proliferation, survival, and cytoskeletal organization 
are activated.
To date, two ITAM co-activating adaptor proteins, Dap12 
and FcR, are established as functional in osteoclasts. Dap12 
associates with its co-receptors, TREM2 and SIRP1, in these 
cells, whereas FcR recognizes OSCAR and PIR-A (Koga 
et al., 2004; Mócsai et al., 2004). Deletion of FcR has no effect 
on the osteoclast, in vitro or in vivo, and knockout animals 
exhibit no skeletal abnormalities. Dap12-deficient BM macro-
phages (BMMs) also normally express markers of osteoclast 
differentiation when exposed to macrophage colony-stimulating 
factor (M-CSF) and receptor activator of nuclear factor B 
ligand (RANKL), but unlike those lacking FcR, fail to opti-
mally organize their cytoskeleton or resorb bone in vitro (Mócsai 
et al., 2004; Zou et al., 2010). This resorptive dysfunction re-
flects absence of the essential role of Dap12 in recruiting Syk to 
the v3-initiated signaling complex (Zou et al., 2008).
Not surprisingly, in face of the purported linear inclusion 
of v3 and Dap12 in the same signaling complex, cultured 
osteoclasts, lacking either protein, have similar façades. In con-
trast to their abnormal in vitro phenotype, however, Dap12/ mice 
contain normal appearing osteoclasts and, again, like those de-
ficient in v3, exhibit only a modest increase in bone mass. 
The preponderance of evidence indicates the paradox of a robust 
In vitro, ligand occupancy of v3 integrin induces phosphorylation of Dap12, which is essential for osteoclast function. Like mice deleted of only v3, 
Dap12/ mice exhibited a slight increase in bone mass, 
but Dap12/ mice, lacking another ITAM protein, FcR, 
were severely osteopetrotic. The mechanism by which 
FcR compensates for Dap12 deficiency is unknown. We 
find that co-deletion of FcR did not exacerbate the skel-
etal phenotype of 3/ mice. In contrast, 3/Dap12 
double-deficient (DAP/3/) mice (but not 1/Dap12 
double-deficient mice) were profoundly osteopetrotic, 
reflecting severe osteoclast dysfunction relative to those 
lacking v3 or Dap12 alone. Activation of OSCAR, 
the FcR co-receptor, rescued Dap12/ but not DAP/
3/osteoclasts. Thus, the absence of v3 precluded 
compensation for Dap12 deficiency by FcR. In keeping 
with this, Syk phosphorylation did not occur in OSCAR-
activated DAP/3/ osteoclasts. Thus, FcR requires 
the osteoclast v3 integrin to normalize the Dap12- 
deficient skeleton.
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DAP/3/ osteoclast cytoskeleton  
is disorganized
Dap12/ and 3/ BMMs, exposed to RANKL and M-CSF, 
differentiate into cells that are universally TRAP expressing 
(Fig. 2 A). Although many multinucleate, they fail to optimally 
spread. RANKL/M-CSF–treated BMMs lacking both Dap12 and 
3 also universally express TRAP. However, the abnormal fea-
tures of DAP/3/ osteoclasts are more striking than those lack-
ing only one gene, as there is no evidence of multinucleation. The 
double-deleted cells also have a crenated facade, indicating 
severe cytoskeletal abnormalities. Although the TRAP-stained 
Dap12/ and 3/ osteoclasts appear to be virtually identical, 
the integrin-deleted cells generate actin rings, which is abnor-
mal; these structures are small and rare in those lacking Dap12 
(Faccio et al., 2003a; Zou et al., 2008; Fig. 2 B). Consistent 
with their more abnormal phenotype, DAP/3/ osteoclasts are 
incapable of producing actin rings. Transduction of DAP/3/ 
BMMs with either Dap12 or 3 yields the TRAP-stained 
phenotype of single gene-deleted osteoclasts (Fig. 2 C). Co-
transduction with both, however, completely normalizes the 
double-deleted cells.
In contrast to their severe morphological abnormalities, 
temporal expression of osteoclast differentiation markers by 
DAP/3/ BMMs is indistinguishable from those lacking 
Dap12, which we have established are unimpaired (Fig. 2 D) 
(Zou et al., 2008). Consistent with intact differentiation 
in vitro, DAP/3/ mice contain normal numbers of osteo-
clasts (Fig. 2 E). DAP/3/ osteoclasts, however, have the ir-
regular appearance of those with dysfunctional cytoskeletons, 
are reduced in size, and attach poorly to bone (Fig. 2, F–H), 
thus yielding decreased eroded trabecular surface (Fig. 2 I). 
Whereas serum CTx, a clinical marker of bone resorption, is 
unaltered in 3/ and Dap12/ mice, it is reduced by 50% 
in those lacking both genes, confirming impaired osteoclast 
activity (Fig. 2 J).
These data confirm attenuated bone resorption in 
DAP/3/ mice. To determine if this abnormality is endog-
enous in the osteoclast or the product of osteoclast-modifying 
cells, such as osteoblasts, we determined the osteoclastogenic 
capacity of various co-cultures of WT and DAP/3/ BMMs 
and osteoblasts. As illustrated in Fig. 2 K, a combination 
of DAP/3/ BMMs and WT osteoblasts yields osteoclasts 
indistinguishable from those derived from pure populations of 
double-deleted progenitors. In contrast, osteoclasts generated 
in co-cultures of WT BMMs and DAP/3/ osteoblasts appear 
to be normal. Thus, the abnormal phenotype of DAP/3/ osteo-
clasts reflects a cell autonomous mechanism.
Bone remodeling is characterized by coupling of bone re-
sorption and formation. Thus, a reasonable hypothesis holds 
that the arrested osteoclastic activity extant in DAP/3/ mice 
would be attended by suppressed osteogenesis. In fact, osteo-
blast abundance and circulating osteocalcin, a specific marker 
of bone formation, are reduced in the mutant animals (Fig. 2 L). 
As arrested bone formation would negatively impact bone mass, 
this observation indicates that the magnitude of osteoclast dys-
function is greater than reflected in the 400% increase in 
DAP/3/ trabecular bone volume.
in vitro osteoclast phenotype and a virtually normal Dap12/ 
skeleton, reflecting in vivo compensation by FcR (Koga et al., 
2004; Mócsai et al., 2004). This posture is underscored by the 
severe osteopetrosis of mice lacking Dap12 and FcR, in com-
bination, despite the absence of a significant skeletal pheno-
type when either is deleted alone. The mechanism by which 
FcR compensates for lack of Dap12 in promoting osteoclast 
function is unknown.
Because 3 and Dap12 are believed to be linear compo-
nents of the same cytoskeleton-organizing signaling complex 
(Zou et al., 2007), we posited that combined deficiency of the 
two would mirror the mild skeletal phenotype characterizing 
single gene deletion of either. To our surprise, mice lacking both 
genes (DAP/3/) exhibit severe osteopetrosis with a 400% 
increase in trabecular bone mass. In contrast, co-deletion of 
FcR and 3 does not alter the 3/phenotype. In keeping 
with the severity of their osteopetrosis, the osteoclasts of DAP/
3/mice effectively differentiate but appear strikingly abnor-
mal, in vitro and in vivo. In contrast co-deletion of Dap12 and 
the 1 integrin (DAP/1/) subunit yields mice with normal 
skeletal mass and osteoclasts indistinguishable from those lack-
ing only Dap12. The unexpected phenotype of DAP/3/ mice 
and its distinction from DAP/1/, establish that the ability of 
FcR to compensate for Dap12 deletion, in osteoclasts, specifi-
cally requires v3. As such, activation of FcR’s co-receptor, 
OSCAR, substantially rescues Dap12/ osteoclasts only in the 
presence of the integrin. Furthermore, absence of Dap12 and 
v3 obviates compensation by other integrins. It also reduces 
phosphorylation of Syk, a tyrosine kinase essential to osteoclast 
cytoskeleton organization. These studies provide a mechanistic 
basis for the enigmatic role of FcR in enabling Dap12- 
deficient osteoclastic bone resorption. They also establish that 
v3 mediates the compensatory properties of ITAM co-
stimulatory proteins in osteoclasts.
Results
DAP/3/ mice are osteopetrotic
DAP/3/ mice are born in Mendelian frequency and like 
those lacking only 3 are predisposed to hemorrhage (McHugh 
et al., 2000). Interestingly, DAP/3/ mice are approximately 
half the size of those deleted of only one of the two genes that 
are indistinguishable from WT (Fig. 1, A and B). Radiographi-
cal and µCT analysis of the distal femurs of 3/ and Dap12/ 
4-wk-old mice mirror that of WT (Fig. 1, C and D). In contrast, 
trabecular bone of DAP/3/ mice is increased by >400%, and 
the long bones are radiodense. These radiographical and µCT 
features are confirmed by histomorphometry (Fig. 1, E and F). 
DAP/3/ bone also contains cartilaginous bars deep within 
the metaphysis, a characteristic feature of osteopetrosis, a fam-
ily of disorders of increased skeletal mass due to arrested re-
sorption (Tolar et al., 2004). Also in keeping with attenuated 
resorption, modeling of DAP/3/ bones is abnormal as evi-
denced by broadening of the distal femoral diaphysis and me-
taphysis (Fig. 1 G).
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osteoclasts identical to those lacking only the integrin, both in 
appearance and bone resorptive capacity (Fig. 3, A and B). Con-
sistent with these in vitro observations, trabecular bone volume 
of FcR/3/ mice is indistinguishable from that of FcR/ 
(Fig. 3 C). Thus, unlike the synergistic effect of Dap12 deletion 
on the phenotype of 3/ osteoclasts, additional absence of 
FcR is inconsequential.
The osteopetrosis of ITAM protein-
deficient, 3/ mice, is Dap12-specific
The negative effect of conjoint Dap12 deletion on 3/ os-
teoclasts raised the question as to whether absence of the other 
osteoclast-expressed ITAM protein, FcR, also impacts these 
3-deficient cells. To address this issue, we crossed FcR/ 
and 3/ mice (FcR/3/). Deletion of the two genes yields 
Figure 1. DAP/3/ mice are osteopetrotic. (A) Photograph illustrating runting of 4-wk-old DAP/3/ mice. (B) Weight of 4-wk-old WT, Dap12/, 
3/, and DAP/3/ mice. (C) µCT (top) and radiographical (bottom) images of femurs of 4-wk-old WT, Dap12/, 3/, and DAP/3/ mice. 
(D) µCT-determined trabecular bone parameters of 4-wk-old WT, Dap12/, 3/, and DAP/3/ mice. (E) Histological sections of tibia of 4-wk-old WT, 
Dap12/, 3/, and DAP/3/ mice stained (right) for TRAP activity to visualize osteoclasts (red reaction product) or (left) with toluidine blue to visual-
ize cartilage (bottom left). High magnification of delineated area illustrates cartilaginous bars (purple reaction product) diagnostic of severe osteopetrosis. 
Bars, 500 µm. (F) Histomorphometric analysis of BV/TV of 4-wk-old WT, Dap12/, 3/, and DAP/3/ mouse tibia. (G) µCT image of 4-wk-old WT, 
Dap12/, 3/, and DAP/3/ mice documenting bone modeling defect in the latter. *, P < 0.05; **, P < 0.01.
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OSCAR-transduced Dap12/ osteoclasts on bone, which con-
tains the natural OSCAR ligand, form actin rings and resorb 
bone; no such effect occurs in DAP/3/ osteoclasts (Fig. 4, 
B–D). On the other hand, OSCAR-FLAG, stimulated by FLAG 
antibody (Ab), converts the appearance of DAP/3/ osteo-
clasts to those exclusively lacking Dap12 only in the presence 
of the 3 integrin (Fig. S1). Consistent with our previous obser-
vation (Zou et al., 2010), OSCAR activation does not regulate 
3 integrin regulates FcR’s capacity  
to rescue Dap12-deficient osteoclasts
These data indicate the compensatory effect of FcR on 
Dap12/ osteoclasts requires v3. To test this hypothesis, we 
used FLAG-tagged OSCAR, which activates FcR when 
stimulated by anti-FLAG Ab (Zou et al., 2010). OSCAR-FcR 
activation increases the capacity of Dap12/ osteoclasts to 
spread only in the presence of v3 (Fig. 4 A). Moreover, 
Figure 2.  DAP/3/ osteoclast cytoskeleton is disorganized. (A) WT, Dap12/, 3/, and DAP/3/ BMMs, cultured on plastic, were exposed 
to M-CSF and RANKL. At day 5, the cells were stained for TRAP activity. Bar, 500 µm. (B) WT, Dap12/, 3/, and DAP/3/ BMMs, cultured on 
bone, were exposed to M-CSF and RANKL. On day 5, the cells were stained with Alexa Fluor 543-phalloidin to visualize actin rings. Bar, 100 µm. 
(C) DAP/3/ BMMs, transduced with Dap12, WT 3, alone, or in combination, were exposed to M-CSF and RANKL. On day 5, the cells were stained 
for TRAP activity. Vector transductants served as control. Bar, 100 µm. (D) Dap12/ and DAP/3/ BMMs were treated with M-CSF and RANKL. Osteo-
clast differentiation proteins were immunoblotted with time. (E) Histomorphometric determination of osteoclast number/mm bone surface in WT, Dap12/, 
3/, and DAP/3/ mice. (F) TRAP-stained histological sections of tibia illustrating attachment of WT (top) osteoclasts to bone and failure of DAP/3/ 
osteoclasts (bottom) to do so. Bar, 50 µm. Histomorphometric quantitation of osteoclast (G) size and (H) number juxtaposed to the bone surface as well 
as (I) percentage of eroded trabecular surface. (J) Serum CTx of WT, Dap12/, 3/ and DAP/3/ mice. (K) TRAP stained co-cultures of WT BMMS 
and WT osteoblasts (top and bottom left, respectively), DAP/3/ BMMs and WT osteoblasts (top right), and WT BMMs and DAP/3/ osteoblasts 
(bottom left). Bars: (top) 100 µm; (bottom) 500 µm. (L) Histomorphometric analysis of osteoblast number/mm bone surface (left) and serum osteocalcin (right). 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Dap12/3 deletion prevents compensatory 
integrin activation
In other cells, 1 integrins activate a cytoskeleton-organizing 
complex similar to that extant in osteoclasts. In fact, 1 inte-
grins recognize Syk in the bone resorptive cells, independent 
of the presence of 3 (Zou et al., 2007). Additionally, M-CSF 
activates the 1 integrin subunit in osteoclasts, as evidenced 
by induced talin binding (Zou et al., 2013). These observations 
raise the possibility that combined deletion of Dap12 and the 
1 integrin may mirror DAP/3/ osteoclasts. We therefore 
mated Dap12/ mice and those bearing 1 floxed alleles. The 
product was crossed to mice expressing LysM Cre, yielding 
animals with myeloid lineage deletion of the 1 integrin and 
global absence of Dap12 (DAP/1/). BMMs obtained from 
these mice were exposed to RANKL and M-CSF, which gener-
ated cells normally expressing osteoclast differentiation mark-
ers (Fig. 6 A). DAP/1/ cells are indistinguishable from those 
lacking only Dap12 (Fig. 6 B). Thus, DAP/1/ osteoclasts 
differ from DAP/3/, which are more abnormal than those 
absent only Dap12. This experiment suggests that unlike 3, 
absence of the 1 integrin does not aggravate the Dap12/  
osteoclast phenotype. This conclusion is supported by the 
osteoclast proliferation (Fig. 4 E), but inhibits apoptosis of 
osteoclasts deprived of M-CSF even in the absence of DAP12 
and the integrin (Fig. 4 F).
These data indicate that OSCAR/FcR and v3 partner 
to compensate for the cytoskeletal consequences of Dap12 dele-
tion in osteoclasts. If this is the case, one would expect FcR 
and/or its activating co-receptor, OSCAR, to associate with the 
integrin. To determine if such is the case, we first transfected 
293T cells with human 3, FcR, and OSCAR-FLAG. Human 
3, whose cytoplasmic domain is identical to that of mouse, 
was used due to availability of an immunoprecipitating mAb. 
Immunoblotting each of the transduced constructs, in 3 
immunoprecipitates establishes that, in the context of overex-
pression, the three proteins associate (Fig. 5 A).
We next asked if FcR/OSCAR association requires the 
integrin in authentic osteoclasts. In fact, FcR and OSCAR co-
immunoprecipitate in DAP/3/ prefusion osteoclasts as ef-
fectively as in WT cells or those lacking Dap12 (Fig. 5 B). 
Furthermore, the 3 integrin associates with OSCAR and FcR 
in primary osteoclastic cells treated with M-CSF or RANKL, 
which promote the capacity of the mature polykaryon to orga-
nize its cytoskeleton (Zou et al., 2008; Fig. 5 C–E).
Figure 3.  The osteopetrosis of ITAM protein/3/ mice is Dap12 specific. (A) WT, 3/, FcR/, and FcR/3/ BMMs, cultured in the presence 
of M-CSF and RANKL for 5 d, were stained for TRAP activity. Bar, 500 µm. (B) WT, 3/, FcR/ and FcR/3/ BMMs were cultured, on bone, 
in the presence of M-CSF and RANKL. After 5 d, the cells were removed and resorption pits were visualized by peroxidase-conjugated wheat germ 
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activation, is substantially more severe than of those lacking 
v3 (Schmidt et al., 2011; Zou et al., 2013). Furthermore, com-
bined deletion of 3 and other integrin subunits yields a much 
more abnormal osteoclast phenotype than absence any  integrin, 
alone (Schmidt et al., 2011).
These observations suggest the robust phenotype of 
DAP/3/ osteoclasts, relative to those lacking only a single 
gene, may reflect functional deficiency of multiple  integrin 
subunits. If true, absence of 3 and Dap12 may incapacitate 
global integrin activators such as talin and thus prevent 1- 
mediated compensation. We therefore exposed 3/, Dap12/, 
and DAP/3/ prefusion osteoclasts to M-CSF, which organizes 
capacity of activated OSCAR to enhance cell spreading, actin 
ring formation and bone resorptive capacity of DAP/1/  
osteoclasts as effectively as those lacking only Dap12 (Fig. 6, 
C–E). Finally, whereas the trabecular bone mass of DAP/3/ 
mice is markedly increased (Fig. 1), DAP/1/ mice mirror 
Dap12/ (Fig. 6 F).
These studies establish that unlike 3, absence of the 1 
integrin does not compromise the Dap12/ osteoclast pheno-
type. On the other hand, the 1 integrin subunit probably com-
pensates, in part, for absence of v3 in osteoclasts (Helfrich 
et al., 1996). For example, osteopetrosis of mice deleted of talin, 
Rap1 or kindlin 3, which are necessary for global  integrin 
Figure 4.  3 integrin regulates FcR’s capacity to rescue DDap12/ osteoclasts. (A) OSCAR-FLAG-transduced Dap12/ or DAP/3/ BMMS were 
plated on IgG- or anti-FLAG Ab–coated plastic. The cells were exposed to RANKL and M-CSF for 5 d and stained for TRAP activity. Bar, 100 µm. 
(B) OSCAR-FLAG-transduced Dap12/ or DAP/3/ BMMS, were plated on bone. The cells were exposed to RANKL and M-CSF for 5 d and stained with 
Alexa Fluor 543–phalloidin to visualize actin rings. Bar, 500 µm. (C) Dap12/ and DAP/3/ BMMs, transduced with OSCAR or vector, were cultured 
on bone in the presence of M-CSF and RANKL. 5 d later, medium CTx content was determined. (D) OSCAR-FLAG–transduced Dap12/ or DAP/3/ 
BMMS were plated on bone. The cells were exposed to RANKL and M-CSF. After 5 d, the cells were removed and resorption pits were visualized by 
peroxidase-conjugated wheat germ agglutinin/horse radish peroxidase staining. Bar, 100 µm. (E) M-CSF–induced proliferation of WT and DAP/3/ 
BMMs as a function of BrdU incorporation. (F) Apoptosis of WT and DAP/3/ serum and M-CSF–deprived preosteoclasts transfected with OSCAR-FLAG 
plated on IgG or anti-FLAG mAb. Data are normalized to WT. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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osteoclasts (Zou et al., 2010). M-CSF, however, fails to stimulate 
Syk phosphorylation on bone-residing osteoclasts in the com-
bined absence of Dap12 and v3. M-CSF stimulates Syk phos-
phorylation in OSCAR- but not in vector-transduced Dap12/ 
osteoclasts generated on bone (Fig. 7 E), indicating its effect is 
mediated by OSCAR. In contrast, M-CSF fails to phosphorylate 
Syk in plastic-residing, OSCAR-transduced Dap12/ osteo-
clasts (Fig. 7 F). Thus, regulation of DAP12/ osteoclast func-
tion, by M-CSF requires FcR activation. The attenuated Syk 
activation in DAP/3/ osteoclasts, even in the presence of ac-
tivated OSCAR, suggests their severe phenotype reflects inabil-
ity of FcR to induce cytoskeleton-organizing signals without 
v3. Furthermore, overexpression of WT Syk in DAP/3/  
osteoclasts does not rescue their morphology (Fig. 7 G) or in-
ability to generate actin rings (Fig. 7 H). Hence, regardless of the 
abundance of the tyrosine kinase, Syk must be activated to or-
ganize the osteoclast cytoskeleton, which can be mediated by 
FcR only in the presence of the v3 integrin.
Discussion
Because resorption requires attachment of osteoclasts to the 
bone surface, we posited that integrins are central to the process. 
A series of in vitro experiments indicated v3 is the principal 
the osteoclast cytoskeleton in a talin/ integrin-dependent man-
ner (Zou et al., 2013). Although M-CSF increases 1/talin as-
sociation in 3/ and Dap12/ cells, the magnitude of binding 
is more robust in the absence of 3 than Dap12 (Fig. 6 G). This 
observation likely reflects lack of competition for talin, by 3, 
in cells lacking the integrin (Calderwood et al., 2004). In con-
trast to the robust 1/talin binding in 3/ cells, DAP/3/ 
osteoclasts exhibit minimal 1/talin association in the presence 
or absence of M-CSF. Thus, 1 integrin activation is enhanced 
in osteoclasts lacking only 3 but compromised by combined 
absence of the 3 subunit and Dap12. This observation explains 
the compensatory effect of 1 in 3/ osteoclasts and its in-
ability to modify DAP/3/ cells.
Syk activation is disrupted in  
DAP/3/ osteoclasts
Syk phosphorylation is central to organization of the osteoclast 
cytoskeleton, whether induced by ligand-mediated (outside-in) 
or M-CSF–stimulated (inside-out) integrin activation (Zou et al., 
2007, 2008). Neither ligand- (Faccio et al., 2003b) nor cytokine- 
activated (Zou et al., 2008) integrins, however, phosphorylate 
Syk in Dap12/ osteoclastic cells maintained on plastic, nor do 
they normalize their cytoskeleton (Faccio et al., 2003a,b; Zou 
et al., 2008).
Although M-CSF also fails to phosphorylate Syk in plastic-
residing Dap12/ osteoclasts, it modestly does so when they 
are cultured on bone (Fig. 7 A). As activated FcR is compensa-
tory for absence of Dap12, this observation is consistent with 
evidence that OSCAR, which activates FcR, is a collagen re-
ceptor and bone matrix is likely a principal source of OSCAR 
ligand (Zou et al., 2010; Barrow et al., 2011). Given the central 
role of Syk in osteoclast function, the profound skeletal pheno-
type of DAP/3/ mice may reflect failure of activated FcR 
to induce cytoskeleton-organizing signals without v3.
We find that OSCAR-FLAG–bearing Dap12/ osteoclasts 
plated on the v3 ligand vitronectin do not phosphorylate 
Syk in the absence of FLAG Ab (Fig. 7 B). Conversely, v3 
occupancy by vitronectin in the presence of FLAG-Ab– 
activated OSCAR promotes Syk phosphorylation. Confirming 
OSCAR-FLAG activates Syk via FcR in Dap12-deficient 
cells, deletion of both ITAM proteins obviates Syk phosphory-
lation by FLAG Ab (Fig. 7 C). Thus, in Dap12/ osteoclasts, 
v3 occupancy and activated FcR trigger a key cytoskeleton-
organizing complex, in a mutually dependent manner.
These studies involved OSCAR stimulation by anti-FLAG 
Ab. We next determined the impact of combined Dap12/3 
deletion on FcR’s capacity to activate Syk in the context of 
physiological OSCAR ligand. To this end, we generated prefu-
sion OSCAR-transduced osteoclasts on bone. We then exposed 
the cells to M-CSF which, by stimulating Rap1 and promoting 
talin association, is a global activator of  integrins (Zou et al., 
2013). Thus, M-CSF in collaboration with  integrins, induces 
Syk-mediated WT osteoclast cytoskeletal organization and 
bone resorption via inside-out integrin activation. M-CSF pro-
motes Syk phosphorylation in OSCAR-transduced, Dap12/  
cells on bone (Fig. 7 D), which is consistent with the capac-
ity of OSCAR to enhance the resorptive activity of Dap12/  
Figure 5.  3 integrin associates with OSCAR and FcR in osteoclasts. 
(A) 293T cells were transfected with human 3, FcR, and OSCAR-FLAG 
(lane 1), FcR and OSCAR-FLAG (lane 2), 3 and FcR (lane 3), FcR (lane 4), 
3 and OSCAR-FLAG (lane 5), or OSCAR-FLAG (lane 6). 3 immuno-
precipitates and total cell lysates were immunoblotted for 3, FcR, and FLAG. 
(B) WT, Dap12/, and DAP/3/ BMMS were transduced with OSCAR-
FLAG. The cells were exposed to RANKL and M-CSF for 3 d. FLAG immuno-
precipitates were immunoblotted for FcR and FLAG. Vector-transduced WT 
cells (first lane) serve as control. (C) WT BMMs, transduced with OSCAR-
FLAG were exposed to RANKL and M-CSF for 3 d. After cytokine/serum 
starvation, the cells were treated with M-CSF. FLAG immunoprecipitates 
were temporally immunoblotted for 3 and OSCAR. IgG immunoprecipi-
tates serve as control. (D) WT BMMs, transduced with OSCAR-FLAG were 
exposed to RANKL and M-CSF for 3 d. After cytokine/serum starvation the 
cells were treated with RANKL and FLAG immunoprecipitates temporally 
immunoblotted for 3 and OSCAR. (E) 3/ BMMs, transduced with human 
3 were exposed to RANKL and M-CSF for 3 d. After cytokine/serum star-
vation, the cells were treated with M-CSF and 3 immunoprecipitates tem-
porally immunoblotted for 3 and FcR.
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bone mass until at least 4 mo of age (Soriano et al., 1991; 
McHugh et al., 2000; Zou et al., 2007; Croke et al., 2011).
Koga et al. (2004) and Mócsai et al. (2004) have docu-
mented that combined deletion of Dap12 and FcR causes 
severe osteopetrosis. The authors reasoned that Dap12 deficiency, 
but not that of FcR, inhibits osteoclast formation in vitro and 
concluded that Dap12 is the principal co-stimulatory molecule 
regulating the bone resorptive cell. Inconsistent with Dap12 me-
diating differentiation of the cell, Mócsai et al. (2004) noted that 
osteoclast maturation markers are normally expressed despite 
integrin in osteoclasts, and thus we engineered mice lacking the 
3 subunit (McHugh et al., 2000). In addition to compromised 
ability to bind matrix, osteoclasts generated from 3/ BMMs 
do not optimally spread, suggesting cytoskeletal dysfunction. In 
fact, such dysfunction represents failure to activate a cytoskeleton-
organizing signaling complex containing the integrin, c-Src, 
and Syk, ultimately leading to activation of the small GTPase 
Rac. Deletion of any component of this complex yields poorly 
spread osteoclasts. Whereas absence of c-Src, Syk, or Rac yields 
severe osteopetrosis, v3-deficient mice exhibit no increase in 
Figure 6.  Dap12/3 deletion prevents compensatory integrin activation. (A) 1fl/fl mice, mated to those lacking Dap12, were crossed to mice expressing 
LysMCre, yielding animals with myeloid lineage deletion of the 1 integrin and global absence of Dap12 (DAP/1/). BMMs were exposed to RANKL and 
M-CSF and the osteoclast differentiation proteins, 3 and c-Src, immunoblotted after 3 d. Dap12//1fl/fl cells (Dap/) serve as control. (B) DAP/1/ and 
DAP/ BMMs, exposed to M-CSF and RANKL for 5 d, were stained for TRAP activity. Bar, 500 µm. (C) DAP/1/ and DAP/ BMMs were transduced with 
OSCAR-FLAG. The cells were plated on IgG or anti-FLAG Ab in the presence of M-CSF and RANKL. After 5 d, the cells were stained for TRAP activity. Bar, 500 µm. 
(D) DAP/1/ and DAP/ BMMs were transduced with OSCAR-FLAG or vector. The cells were plated on bone in the presence of M-CSF and RANKL. After 
5 d, the cells were stained with Alexa Fluor 543-phalloidin to visualize actin rings. Bar, 100 µm. (E) DAP/1/ and DAP/ BMMs were transduced with 
OSCAR-FLAG or vector. The cells were plated on bone in the presence of M-CSF and RANKL. After 5 d, the cells were removed and resorption pits were 
visualized by peroxidase-conjugated wheat germ agglutinin/horse radish peroxidase staining. Bar, 100 µm. (F) DAP/1/ and DAP/ mouse tibia were 
subjected to µCT analysis and BV/TV determined. (G) 3/, Dap12/, and DAP/1/ BMMs were treated with RANKL and M-CSF for 3 d. Cytokine/
serum starved cells were exposed to M-CSF (+) or PBS () for 5. 1 immunoprecipitates were immunoblotted for talin and 1.
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This study addresses the unresolved issue regarding the 
means by which FcR compensates for the absence of Dap12 in 
regulating osteoclastic bone resorption. We find that combined 
deletion of Dap12 and 3 yields severe osteopetrosis whereas 
absence of either of the two genes, alone, has minimal skeletal 
impact. This observation is unexpected in light of the linear sig-
naling relationship of Dap12 and 3 and establishes the integrin 
is necessary for FcR to exert its compensatory effect. Like in-
dividual deletion of either the ITAM protein or integrin, their 
combined absence does not affect expression of osteoclast dif-
ferentiation markers but causes substantially more severe cyto-
skeletal abnormalities. Our challenge was to determine the 
absence of the ITAM protein. Subsequent studies establish that 
the principal effect of Dap12 deficiency, in osteoclasts, is not ar-
rested differentiation but cytoskeletal and resorptive dysfunc-
tion whether or not FcR is co-deleted (Zou et al., 2007, 2010)
Perhaps the most surprising feature of these two studies 
is the discrepancy between the in vitro appearance of Dap12/ 
osteoclasts and lack of an impressive bone phenotype. Using co- 
cultures of mutant osteoclast linage cells and WT osteoblasts, both 
groups proposed that the absence of osteopetrosis in Dap12/ 
mice reflects compensation by FcR. These experiments also 
raised the likelihood of an osteoblast-produced ligand recogniz-
ing FcR co-receptors such as OSCAR or PIR-A.
Figure 7. Syk activation is disrupted in DAP/3/ osteoclasts.. (A) WT and Dap12/ BMMs were cultured on bone for 3 d in the presence of RANKL and 
M-CSF. Cytokine/serum starved cells were exposed to M-CSF or PBS for 30 min. Syk immunoprecipitates were immunoblotted with an antiphosphotyrosine 
mAb. (B) Dap12/ BMMs, transduced with OSCAR-FLAG or vector were exposed to M-CSF and RANKL for 3 d. The cells were suspended and cytokine/
serum starved, after which they were maintained in suspension (lane 1) or plated on vitronectin (lane 2) or vitronectin + anti-FLAG Ab (lane 3). Syk immuno-
precipitates were immunoblotted with an anti-phosphotyrosine mAb. (C) Dap12/ and Dap12//FcR/ BMMs, transduced with OSCAR-FLAG were ex-
posed to M-CSF and RANKL for 3 d. The cells were suspended and cytokine/serum starved, after which they were maintained in suspension (lane 1) or plated 
on vitronectin (lane 2) or vitronectin + anti-FLAG mAb (lane 3). Syk immunoprecipitates were immunoblotted with an antiphosphotyrosine mAb. (D) Dap12/ 
and DAP/3/ BMMs, transduced with OSCAR-FLAG, were exposed to M-CSF and RANKL, on bone, for 3 d. The cells were cytokine/serum starved, after 
which they were exposed to M-CSF or PBS for 5 min. Syk immunoprecipitates were immunoblotted with an antiphosphotyrosine mAb. (E) Dap12/ BMMs, 
transduced with OSCAR-FLAG or vector and plated on bone, were exposed to M-CSF and RANKL for 3 d. Cells were cytokine/serum starved after which they 
were exposed to M-CSF for 5 min. Syk immunoprecipitates were immunoblotted with an antiphosphotyrosine mAb. (F) Dap12/ BMMs, transduced with 
OSCAR-FLAG or vector, were cultured on plastic in the absence of anti-FLAG mAb, for 3 d. Cytokine/serum starved cells were exposed to M-CSF or PBS for 
5 min, after which Syk immunoprecipitates were immunoblotted with an anti-phosphotyrosine mAb. Vector-transduced WT cells serve as control. (G and H) 
Syk/ and DAP/3/ BMMs transduced with Syk or vector were cultured in the presence of M-CSF and RANKL on plastic (left) or (right) bone. After 5 d, 
plastic-residing cells were stained for TRAP activity and those on bone were stained with Alexa Fluor 488-phalloidin to visualize actin rings. Bar, 100 µm.
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cytoskeletal organization (Zou et al., 2008). Consistent with 
OSCAR ligand being a collagen peptide, M-CSF phosphory-
lates Syk, albeit modestly, in Dap12/ osteoclasts cultured on 
bone, a phenomenon accentuated by enhancing OSCAR ex-
pression. Although the reason why FcR-mediated Syk phos-
phorylation is not optimized with physiological expression of 
OSCAR is unknown, it may represent competition by inhibitory 
receptors, such as PIR-B and FcRII, expressed by osteoclasts 
(Koga et al., 2004).
M-CSF also phosphorylates Syk in the absence of Dap12, 
but fails to do so in DAP/3/ osteoclasts. It appears, there-
fore, that whereas other integrins may partially compensate 
for lack of 3 in the presence of only Dap12 signaling, such 
is not the case in the context of FcR. This posture is in keep-
ing with the fact that combined deletion of FcR and 3 
yields osteoclasts indistinguishable from those lacking only 
the integrin and helps explain the dramatic skeletal pheno-
type of DAP/3/ mice.
These studies establish that the machinery compensating 
for absence of Dap12 or v3 is ineffective when both are de-
leted and suggest the following model (Fig. 8). In WT osteo-
clasts Dap12 binds to liganded, high affinity v3 to induce 
cytoskeletal organization. In the absence of Dap12, FcR sub-
stitutes by associating with v3. When v3 is lacking, other 
activated  integrins, such as those containing 1, effectively 
compensate. In contrast, normalization of osteoclasts lacking 
both Dap12 and v3, by FcR, is not possible as activation 
of compensatory integrins is arrested.
Recent evidence indicates that arrest of osteoclast func-
tion is a more effective means of inhibiting bone loss than is 
diminution of cell number (Williams et al., 2013). The osteo-
clast cytoskeleton presents as a candidate therapeutic target in 
this regard, thus the mechanism by which the osteoclast orga-
nizes its cytoskeleton is important. In fact, blockade of v3 
has bone-sparing effects in osteoporotic women (Murphy et al., 
2005). The present study underscores the unique and central 
role the integrin plays in osteoclast function and provides in-
sights into how it does so in association with Dap12 and FcR.
Materials and methods
Mice
3/ mice were generated by using a targeting construct in which a 1.2-kb 
genomic fragment (including 300 bp of the promoter, the transcriptional 
start site, exon I, intron I, and exon II) was replaced by a phosphoglycerokinase 
promoter-neomycin resistance gene cassette (McHugh et al., 2000). 
Dap12/ mice were provided by T. Takai (Tohoku University, Sendai, 
Japan), and were generated by standard gene-targeting methods that re-
sulted in the deletion of a putative promoter and exons 1–3 of Dap12 
(Kaifu et al., 2003). Dap12//3/ mice were generated by crossing 
between Dap12//3+/males and females obtained by mating of 
Dap12/ mice with 3/ mice. 1fl/fl mice and Lys M-Cre mice were ob-
tained from The Jackson Laboratory. FcR/ mice, generated by a neomy-
cin selection cassette, were inserted into exon2 creating a stop codon 
downstream of the integration site (Takai et al., 1994). Dap12//FcR/, 
generated by cross mating of DAP12/ mice with FcR/ mice, were 
provided by M. Colonna (Washington University School of Medicine, 
St. Louis, MO). All mice were housed in the animal care unit of Washington 
University School of Medicine, where they were maintained according to 
guidelines of the Association for Assessment and Accreditation of Laboratory 
Animal Care. All animal experimentation was approved by the Animal 
Studies Committee of Washington University School of Medicine.
molecular mechanism whereby v3 mediates the salutary 
properties of FcR on Dap12/ osteoclasts.
We documented that Dap12 exerts it cytoskeletal effects, 
in osteoclasts, by processes involving v3 and M-CSF (Zou 
et al., 2007, 2008). This event entails activation of Rap1 which 
promotes talin association with  integrin cytoplasmic domains 
(Zou et al., 2013). The complex transits the integrin to its high 
affinity, ligand-binding state, thus inducing its cytoskeleton- 
organizing effectors. This observation is in keeping with evidence 
that other  integrins, particularly 1 which recognizes Syk, 
may compensate, in some circumstances, for absence of v3 
(Kamiguti et al., 2000). Although not yet confirmed in vivo, multi-
ple integrin deletion in vitro yields a more severe cytoskeletal phe-
notype than absence of only one subunit (Schmidt et al., 2011).
Compensation of 3 deficiency, by 1, does not occur 
with co-deletion of Dap12. This observation also explains the 
mild skeletal effects of 3 deficiency compared with the robust 
osteopetrosis attending absence of talin, Rap1, or kindlin3 each 
of which globally targets  integrins. Failure of M-CSF to pro-
mote talin association with the 1 subunit in DAP/3/ cells, 
while it does so in those lacking a single gene, provides the key 
mechanistic insight into the severe osteopetrosis of DAP/3/ 
mice and why v3 is required for FcR-mediated rescue of 
Dap12/ osteoclasts. Suppression of 1/talin association by 
Dap12/3 deletion is, however, surprising in light of evidence 
that 3 exerts a transdominant effect on 1 activation (Das et al., 
2014). This transdominant effect is consistent with the robust 
interaction of talin and 1 in M-CSF–stimulated 3/ osteo-
clasts (Zou et al., 2013). Thus, in the presence of Dap12, 3 de-
letion activates other integrins whereas in the absence of Dap12, 
3 deficiency is suppressive. We believe these data provide the 
first example of deletion of a specific integrin activating or sup-
pressing another, depending upon circumstance (Kamiguti et al., 
2000). Although failure to activate 1 is likely central to the 
DAP/3/ skeletal phenotype, DAP/1/ mice and osteo-
clasts are indistinguishable from those lacking only Dap12. The 
essential partnership with FcR, in rescue of Dap12 deficiency 
is, therefore, likely unique to v3.
Having noted that absence of v3 and Dap12 obviates 
inside-out stimulation of a compensatory integrin, we turned to 
its effect on cytoskeletal signaling. We focused on Syk, as its 
activation is essential to osteoclast cytoskeletal organization, 
regardless of the inductive event. Furthermore, Syk has an es-
tablished relationship with v3 and ITAM proteins in the bone 
resorptive cell (Zou et al., 2007, 2008). Importantly, Dap12- 
induced signaling, in osteoclasts, is universally mediated by Syk, 
deletion of which also does not impair differentiation of these 
cells but disrupts their cytoskeleton (Zou et al., 2007). Upon inte-
grin occupancy, liganded Dap12 is recruited to the 3 cytoplasmic 
domain, where it undergoes c-Src–mediated phosphorylation 
of its ITAM tyrosines which, in turn, recruit Syk (Zou et al., 
2007). Subsequent phosphorylation of Syk activates a canoni-
cal, Rac-containing, cytoskeleton-organizing complex. A similar 
Syk-dependent pathway is activated by M-CSF via talin asso-
ciation with 3 or 1 subunits, thereby promoting mutual com-
pensation by the integrins (Zou et al., 2013). Thus, an integrin 
in addition to v3, also links M-CSF to Dap12/Syk-mediated 
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the presence of M-CSF and 1 µg/ml blasticidin (EMD Millipore) for 3 d 
before use as osteoclast precursors.
Actin ring and bone resorptive pit visualization
For actin ring staining, cells were cultured on bovine bone slices in the 
presence of M-CSF and RANKL for 6 d, after which cells were fixed in 4% 
paraformaldehyde, permeabilized in 0.1% Triton X-100, rinsed in PBS, 
and immunostained with Alexa Fluor 488-phalloidin (Molecular Probes). To 
quantitate resorption lacunae, cells were removed from bone slices with me-
chanical agitation. Bone slices were incubated with peroxidase-conjugated 
wheat germ agglutinin (WGA; Sigma-Aldrich) for 1 h and stained with 
3,3-diaminobenzidine (Sigma-Aldrich).
Western blot analysis and immunoprecipitation
Cultured cells were washed twice with ice-cold PBS and lysed in radio-
immune precipitation assay (RIPA) buffer containing 20 mm Tris-HCl, pH 7.5, 
150 mm NaCl, 1 mm EDTA, 1 mm EGTA, 1% Triton X-100, 2.5 mm sodium 
pyrophosphate, 1 mm -glycerophosphate, 1 mm Na3VO4, 1 mm NaF, and 
1× protease inhibitor mixture (Roche). Total cell lysates were prepared 
by homogenizing tissue in TNE lysis buffer consisting of 1% Triton X-100, 
150 mM NaCl, 50 mM Tris, pH 7.4, and 2 mM EDTA supplemented with 
protease and phosphatase inhibitors. After incubation on ice for 10 min, cell 
lysates were clarified by centrifugation at 15,000 rpm for 10 min. 40 µg of 
total lysates were subjected to 8–12% sodium dodecyl sulfate PAGE and 
transferred onto PVDF membranes. Filters were blocked in 0.1% casein in 
PBS for 1 h and incubated with primary antibodies at 4°C overnight, fol-
lowed by probing with either fluorescence-labeled secondary antibodies 
(Jackson ImmunoResearch Laboratories) or HRP-labeled secondary antibod-
ies (Santa Cruz Biotechnology, Inc.). Proteins were detected with the Odyssey 
Infrared Imaging System (LI-COR Biosciences) or SuperSignal ECL solution 
(Thermo Fisher Scientific). For immunoprecipitation, 1 mg of protein was in-
cubated with Ab at 4°C overnight with rotation. Protein A/G agarose (Santa 
Cruz Biotechnology, Inc.) was then added and incubated with rotation for 
3 h at 4°C. Immunoprecipitates were washed three times in lysis buffer and 
the beads were boiled in 2× SDS sample buffer for 5 min. After centrifuga-
tion, proteins were separated by 8% SDS polyacrylamide gels.
Proliferation assay
Macrophages (plated in 96-well dishes at a density of 5,000 cells/well) 
were maintained for 3 d in -10 medium with 20 ng/ml M-CSF and 
100 ng/ml RANKL and labeled with BrdU for the last 3 h of culture. BrdU in-
corporation was determined using the Biotrak ELISA system (GE Healthcare).
Apoptosis assay
Macrophages (plated in 96-well dishes) were cultured with 20 ng/ml 
M-CSF and 100 ng/ml RANKL for 3 d. Cells were deprived of M-CSF 
for 5 h. Cell death was analyzed in quadruplicate using cell death detec-
tion ELISAPLUS kit (Roche), which detects cytoplasmic histone-associated 
DNA fragmentation.
Serum biomarkers
Blood was collected under anesthesia. Serum CTx concentration was deter-
mined with the RatLaps ELISA kit (Nordic Bioscience Diagnostics AS). 
Reagents
Recombinant murine M-CSF was obtained from R&D Systems. Glutathione-S-
transferase (GST)-RANKL was expressed in our laboratory. The GST-RANKL 
vector was constructed by PCR cloning a SalI/NotI fragment corresponding 
to amino acids 158–316 of murine RANKL from osteoblast cDNA (for-
ward primer, 5-ATGTGGCCCGTCGACGCAAGCCTGAGGCCCAGCC-3; 
reverse primer, 5-AAACATCTAGGGCGGCCGCGCTAATG-3) and clon-
ing into pGEX-4T-1 (GE Healthcare). Both strands were sequenced. High- 
expressing BL21 (Stratagene) cells were lysed under nondenaturing conditions 
and GST-RANKL was purified over a glutathione-Sepharose column followed 
by ion exchange chromatography (Lam et al., 2000). The sources of antibod-
ies were as follows: rabbit anti-integrin 3 (Cell Signaling Technology); mouse 
antiphosphotyrosine (4G10), rabbit anti-FcR from Millipore; mouse anti-
NFATc1 and rabbit anti-Syk (N19; Santa Cruz Biotechnology, Inc.); mouse 
anti-Flag Ab, rabbit anti-Flag Ab, mouse anti-Talin Ab, and mouse anti-
actin Ab (Sigma-Aldrich); mouse anti-HA Ab (Covance); goat anti-OSCAR 
Ab (R&D Systems); rabbit anti-1 Ab (Abcam). All other chemicals were 
obtained from Sigma-Aldrich.
Macrophage isolation and osteoclast culture
Marrow was extracted from femora and tibiae of 4–8-wk-old mice with 
-MEM and cultured in -MEM containing 10% inactivated fetal bovine 
serum, 100 IU/ml penicillin, and 100 µg/ml streptomycin (-10 medium) 
with 1:10 CMG condition media on Petri-plastic dishes. Cells were incu-
bated at 37°C in 6% CO2 for 3 d, and then washed with PBS and lifted 
with 1× trypsin/EDTA (Invitrogen) in PBS. A total of 5 × 103 cells were cul-
tured in 200 µl -MEM containing 10% heat-inactivated FBS with GST-
RANKL and 30 ng/ml of mouse recombinant M-CSF in 96-well tissue 
culture plates, some containing sterile bone slices. For some experiments, 
cell culture plates were coated with 10 µg/ml anti-Flag Ab or IgG over-
night at 4°C before cells were plated. Cells were fixed and stained for 
tartrate-resistant acid phosphatase (TRAP) activity after 6 d in culture, using 
a commercial kit (387-A; Sigma-Aldrich).
Calvarial osteoblast isolation and co-culture
Primary osteoblasts were extracted from 3–5-d-old neonatal calvariae with 
collagenase. 1.2 × 104 osteoblasts and 3 × 104 macrophages were mixed 
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(Biomedical Technologies Inc.).
Microcomputed tomography (CT)
The trabecular volume in the distal femoral metaphysis or proximal tibia 
was measured using a Scanco CT40 scanner (Scanco Medical AG). 
A threshold of 220 was used for evaluation of all scans. 40–100 slices 
were analyzed, starting with the first slice in which condyles and primary 
spongiosa were no longer visible.
Histology and histomorphometry
The mice tibiae were fixed with 10% neutral buffered formalin, followed by 
decalcification in 14% EDTA for 10 d, paraffin embedding, and TRAP 
staining. Osteoclastic and osteoblastic perimeters were measured and ana-
lyzed using BioQuant OsteoII (BioQuant Image Analysis Corporation) in 
a blinded fashion.
Statistics
Statistical significance was determined using Student’s t test or ANOVA. 
*, P < 0.05; **, P < 0.01; ***, P < 0.001 in all experiments.
Image acquisition and manipulation
Images from Fig. 1 E, Fig. 2 (A–C, F, and K), Fig. 3 (A and B), Fig. 4 (A, B, 
and D), Fig. 6 (B–E), Fig. 7 (G and H), and Fig. S1 were acquired using 
a microscope (Eclipse E400; Nikon) with plan Fluor lenses at room temper-
ature. No imaging media were used except for Fig. 2 F. Zimmerson oil (Thermo 
Fisher Scientific) served as the imaging medium in Fig. 2 F. Fluorochrome 
Alexa Fluor 543 was used in Fig. 2 B, Fig. 4 B, and Fig. 6 D. Fluorochrome 
FITC was used in Fig. 7 H and Fig. S1. Photographs were taken with a camera 
(Nikon Digital Sight DS-Fi1) and displayed with NIS-Elements software (F3.0) 
in all circumstances except Fig. 1 A. The images were organized in Photo-
shop (version 7.0.1; Adobe). Fig. 1 A was acquired with a digital camera 
(Powershot A75; Canon) and organized in Photoshop.
Online supplemental material
Fig. S1 shows that in the presence of 3 integrin, OSCAR activation in-
creases DAP/3/ osteoclast spreading and rescues DAP/3/ osteo-
clast function on bone. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201410123/DC1.
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